These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6573687)
1. Protective effect of a thromboxane synthetase inhibitor, OKY-1581, on increased lung vascular permeability in pulmonary microembolization in dogs. Hirose T; Aoki E; Domae M; Ishibashi M; Ikeda T; Tanaka K Prostaglandins Leukot Med; 1983 Feb; 10(2):187-96. PubMed ID: 6573687 [TBL] [Abstract][Full Text] [Related]
2. The potential beneficial effect of a thromboxane synthetase inhibitor, OKY-1581, on increased lung vascular permeability in experimental pulmonary microembolization in dogs. Hirose T; Aoki E; Aizawa H; Ishibashi M; Domae M; Ikeda T; Tanaka K Jpn J Med; 1982 Jul; 21(3):180-6. PubMed ID: 6890592 [TBL] [Abstract][Full Text] [Related]
3. Effect of OKY 046, a thromboxane synthase inhibitor, on lung vascular permeability after pulmonary embolism in sheep. Lelcuk S; Klausner JM; Merhav A; Rozin RR Thorax; 1987 Sep; 42(9):676-80. PubMed ID: 3686459 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581. Garcia-Szabo R; Kern DF; Malik AB Prostaglandins; 1984 Dec; 28(6):851-66. PubMed ID: 6543018 [TBL] [Abstract][Full Text] [Related]
5. The effect of prostacyclin infusion on increased pulmonary vascular permeability following microembolization in dogs. Hirose T; Aoki E; Domae M; Ishibashi M; Ikeda T; Tanaka K Prostaglandins Leukot Med; 1983 May; 11(1):51-61. PubMed ID: 6348802 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of permeability lung injury after phorbol myristate acetate by verapamil and OKY-046. Allison RC; Marble KT; Hernandez EM; Townsley MI; Taylor AE Am Rev Respir Dis; 1986 Jul; 134(1):93-100. PubMed ID: 3729167 [TBL] [Abstract][Full Text] [Related]
7. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. Kubo K; Kobayashi T Am Rev Respir Dis; 1985 Sep; 132(3):494-9. PubMed ID: 3898941 [TBL] [Abstract][Full Text] [Related]
8. The effect of prostacyclin on increased hydraulic conductivity of pulmonary exchange vessels following microembolization in dogs. Hirose T; Aoki E; Ishibashi M; Domae M; Ikeda T; Tanaka K Microvasc Res; 1983 Sep; 26(2):193-204. PubMed ID: 6353175 [TBL] [Abstract][Full Text] [Related]
9. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. Ishihara Y; Uchida Y; Kitamura S Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388 [TBL] [Abstract][Full Text] [Related]
10. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog. Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR Eur J Pharmacol; 1984 Oct; 105(3-4):285-91. PubMed ID: 6542526 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid. Tod ML; Cassin S J Appl Physiol (1985); 1985 Mar; 58(3):710-6. PubMed ID: 3920192 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia. Burke SE; Lefer DJ; Lefer AM Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001 [TBL] [Abstract][Full Text] [Related]
15. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium. McCluskey ER; Kramer JB; Corr PB; Needleman P Biochem Biophys Res Commun; 1984 Jun; 121(2):552-7. PubMed ID: 6539597 [TBL] [Abstract][Full Text] [Related]
16. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep. Sugi K; Esato K Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815 [TBL] [Abstract][Full Text] [Related]
17. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
18. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H Stroke; 1985; 16(2):241-4. PubMed ID: 3883580 [TBL] [Abstract][Full Text] [Related]
19. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs. Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822 [TBL] [Abstract][Full Text] [Related]
20. Role of thromboxane in interleukin 2-induced lung injury in sheep. Klausner JM; Paterson IS; Morel NM; Goldman G; Gray AD; Valeri R; Eberlein TJ; Shepro D; Hechtman HB Cancer Res; 1989 Jul; 49(13):3542-9. PubMed ID: 2786452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]